Intellia Therapeutics, Inc. NTLA
10.24 USD +0.71 (+7.51%)
As ofNov 20, 2026, 1:38 PM EST
9.30 Day range 10.40
7.95 52-week range 18.48
- YTD
- +13.85%
- 1 year
- +27.30%
Held by funds
114 US ETFs and mutual funds hold NTLA · largest positions
- ARKK 1.29% of fund $136.42M
- XBI 0.46% of fund $47.76M
- VTI 0.00% of fund $42.58M
- VB 0.02% of fund $39.24M
- IWM 0.05% of fund $37.85M
- ARKG 1.75% of fund $33.92M
- NJM 0.04% of fund $33.86M
- FBIOX 0.39% of fund $23.09M
- VBK 0.05% of fund $21.93M
- VXF 0.02% of fund $19.95M
- FSSNX 0.06% of fund $19.00M
- FPHAX 1.02% of fund $16.41M
- IWN 0.10% of fund $13.70M
- NAJ 0.09% of fund $12.44M
- IBB 0.10% of fund $10.80M
- VTWO 0.06% of fund $10.09M
- VSEQX 0.08% of fund $9.98M
- SHSSX 0.13% of fund $8.02M
- FSMAX 0.02% of fund $7.93M
- DFAS 0.02% of fund $7.71M
Ownership
- Institutions 93.2%
- Insiders 3.97%
- Public and other holders 2.84%
Held by insiders 3.97%
Held by institutions 93.19%
Float held by institutions 97.04%
Institutions 421
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 11.42% | 16,035,423 | 152.66M | Sep 29, 2026 |
| ARK Investment Management, LLC | 11.35% | 15,925,221 | 151.61M | Sep 29, 2026 |
| State Street Corporation | 5.56% | 7,809,060 | 74.34M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 5.26% | 7,389,669 | 70.35M | Sep 29, 2026 |
| Shaw D.E. & Co., Inc. | 4.32% | 6,064,717 | 57.74M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.30% | 6,041,599 | 57.52M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK ETF Trust-ARK Innovation ETF | 7.88% | 11,062,565 | 105.32M | Oct 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.05% | 4,286,200 | 40.80M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.05% | 4,286,323 | 40.81M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.54% | 3,564,714 | 33.94M | Sep 29, 2026 |
| ARK ETF Trust-ARK Genomic Revolution ETF | 2.40% | 3,371,851 | 32.10M | Oct 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.21% | 3,106,242 | 29.57M | Jun 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BASTA JAMES EDMUND | General Counsel | Sale | Mar 1, 2026 | 156,794 |
| CHASE WILLIAM J | Director | Stock Award(Grant) | Jun 8, 2026 | 143,893 |
| CLARK ELIANA | Chief Technology Officer | Sale | Mar 1, 2026 | 93,864 |
| COHEN FREDERICK E. M.D. PH.D. | Director | Stock Award(Grant) | Jun 8, 2026 | 216,653 |
| DULAC EDWARD J III | Chief Financial Officer | Sale | Jul 21, 2026 | 148,175 |
| LEBWOHL DAVID | Officer | Stock Award(Grant) | Feb 26, 2026 | 131,192 |
